Clinical Trials Browser

Phase 2 × NIH × Immunologic Techniques × Clear all

NCT00742404 2013-12-18

Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Phase 2 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell